Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?
The drugmaker badly needs more clinical wins.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Health & Medicine
1 in 5 Older Americans Take Medications That Could Cause Major Interactions
Many older Americans still face potentially dangerous drug interactions as prescription and supplement use rises.
- Over 22% of Americans aged 62-85 take medications with major interaction risks.
- Polypharmacy increased from 31% to 35.7% between 2015-2016 and 2021-2023.
- Elderly drug-drug interaction exposure remains high despite slight decrease.
Ebola outbreak expands to 63 health zones in DR Congo
The Ebola outbreak in the Democratic Republic of Congo has expanded to 63 health zones, with 7,890 confirmed cases and 3,799 deaths reported by the WHO.
Health Ministry moves to integrate traditional medicine into mainstream healthcare
The Deputy Minister for Health, Prof. Dr Grace Ayensu-Danquah, has called for greater integration of scientifically validated traditional medicine into Ghana’s mainstream healthcare system.
Push to stop girls having to suffer pelvic pain in silence
Advocates are calling for specialist endometriosis education in NSW public schools to make it less awkward for students and teachers to discuss the condition.
Afternoon front page: CBC journalist disciplined over post on anti-Israel protest; synagogue attacker sued military over COVID vaccine mandate; and more
Catch up on the stories we’re following today